AIDS-related Kaposi's sarcoma in New York City in 1977
Biggar, R.J.; Nasca, P.C.; Burnett, W.S.
New England Journal of Medicine 318(4): 252
1988
ISSN/ISBN: 0028-4793 PMID: 3336414 Document Number: 322547
Document emailed within 1 workday
Related Documents
Murakami-Mori, K.; Mori, S.; Taga, T.; Kishimoto, T.; Nakamura, S. 1997: Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation Journal of Immunology 158(11): 5518-5526Thomas, P.A.; Weisfuse, I.B.; Greenberg, A.E.; Bernard, G.A.; Tytun, A.; Stellman, S.D. 1993: Trends in the first ten years of AIDS in New York City. The New York City Department of Health AIDS Surveillance Team American Journal of Epidemiology 137(2): 121-133
Von Overbeck, J.; Perey, L.; Iten, A.; Pechère, M.; Ruffieux, P.; Hirschel, B. 1995: Human chronic gonadotropin for AIDS-related Kaposi's sarcoma Lancet 346(8975): 642-643
Mallery, S.R.; Bailer, R.T.; Hohl, C.M.; Ng-Bautista, C.L.; Ness, G.M.; Livingston, B.E.; Hout, B.L.; Stephens, R.E.; Brierley, G.P. 1995: Cultured AIDS-related Kaposi's sarcoma (AIDS-KS) cells demonstrate impaired bioenergetic adaptation to oxidant challenge: implication for oxidant stress in AIDS-KS pathogenesis Journal of Cellular Biochemistry 59(3): 317-328
Ghyka, G.; Alecu, M.; Hălălău, F.; Călugăru, A.; Coman, G. 1991: Human leukocyte interferon treatment associated with IL-2 in the non-AIDS related Kaposi's sarcoma Romanian Journal of Internal Medicine 29(1-2): 75-83
Dezube, B.J.; Pantanowitz, L.; Aboulafia, D.M. 2004: Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment Aids Reader 14(5): 236-8 243-4 251-3
Alecu, M.; Ghyka, G.; Hălălău, F.; Călugăru, A.; Coman, G. 1990: Intralesional human leukocyte interferon treatment in the non-AIDS related Kaposi's sarcoma Medecine Interne 28(1): 61-67
Pompili, G.G.; Dellafiore, L.; Soldi, S.; Alineri, S.; Bonetto, S.; Santambrogio, S.; Cornalba, G. 1998: AIDS-related pulmonary Kaposi's sarcoma: role of high-resolution computerized tomography La Radiologia Medica 96(4): 318-324
Borleffs, J.C.; Hoepelman, I.M.; van der Ende, M.E.; van Leusen, R.; van 't Wout, J.W. 1991: Triple therapy with vinblastine, interferon-alpha 2a and zidovudine for AIDS-related Kaposi's sarcoma Journal of Acquired Immune Deficiency Syndromes 4(11): 1161-1162
Mitsuyasu, R.T. 1989: The enhanced potential use of recombinant alpha interferon in the treatment of AIDS-related Kaposi's sarcoma Oncology Nursing Forum 16(6): 5-7
Hermans, P.; Lundgren, J.; Sommereijns, B.; Pedersen, C.; Vella, S.; Katlama, C.; Lüthy, R.; Pinching, A.J.; Gerstoft, J.; Pehrson, P.; Clumeck, N. 1996: Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study Group Aids 10(8): 911-917
Roth, W.K.; Werner, S.; Schirren, C.G.; Hofschneider, P.H. 1989: Depletion of PDGF from serum inhibits growth of AIDS-related and sporadic Kaposi's sarcoma cells in culture Oncogene 4(4): 483-487
Rasokat, H.; Häussermann, L.; Bauermeister-Jasso, K. 1985: Sporadic, endemic and AIDS-related Kaposi's sarcoma. Different clinical course variants of the tumor demonstrated by 3 typical cases Zeitschrift für Hautkrankheiten 60(1-2): 109-115
Gill, P.S.; Espina, B.M.; Moudgil, T.; Kidane, S.; Esplin, J.A.; Tulpule, A.; Levine, A.M. 1994: All-trans retinoic acid for the treatment of AIDS-related Kaposi's sarcoma: results of a pilot phase II study Leukemia 8(Suppl): S26-S32
Murakami-Mori, K.; Mori, S.; Bonavida, B.; Nakamura, S. 1999: Implication of TNF receptor-I-mediated extracellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: a possible role of a novel death domain protein MADD in TNF-alpha-induced ERK1/2 activation in Kaposi's sarcoma cells Journal of Immunology 162(6): 3672-3679
Warmuth, I.; Moore, P.S. 1997: Kaposi sarcoma, Kaposi sarcoma-associated herpesvirus, and human T-cell lymphotropic virus type 1. what is the current evidence for causality? Archives of Dermatology 133(1): 83-85
Olsen, S.J.; Chang, Y.; Moore, P.S.; Biggar, R.J.; Melbye, M. 1998: Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985 Aids 12(14): 1921-1925
Tozetto-Mendoza, T.R.; Ibrahim, K.Y.; Tateno, A.F.; de Oliveira, C.M.; Sumita, L.M.; Sanchez, M.C.A.; Luna, E.J.é; Pierrotti, L.C.; Drexler, J.F.; Braz-Silva, P.H.; Pannuti, C.S.ér.; Romano, C.M. 2016: Genotypic distribution of HHV-8 in AIDS individuals without and with Kaposi sarcoma: Is genotype B associated with better prognosis of AIDS-KS? Medicine 95(48): E5291
Betlloch Mas, I.; Jiménez Martínez, A.; Ramón Quiles, D.; Castells Rodellas, A. 1987: Kaposi's sarcoma as the first manifestation of AIDS Medicina Cutanea Ibero-Latino-Americana 15(2): 98-104
Dhrif, A.S.; Kilani, B.; Ammari, L.; Kanoun, F.; Tiouri, H.; Ben Chaaben, T. 2007: AIDS-associated Kaposi's sarcoma: 22 cases La Tunisie Medicale 85(6): 494-499